The Stalling Progress Against Tuberculosis

After nearly two decades of consistent advancements in combating tuberculosis (TB) across europe, recent data indicates a concerning slowdown in progress. Following a meaningful drop in TB cases in 2020, attributed to the COVID-19 pandemic adn associated lockdowns, the number of infections on the continent has begun to climb again.

Rising Case Numbers in the EU/EEA

In 2023, approximately 39,000 cases of tuberculosis were reported within the European Union (EU) and the European Economic Area (EEA). This figure represents an increase of roughly one thousand cases compared to the previous year, signaling a worrying trend reversal.

While the overall notification rate of TB in the EU/EEA has generally been decreasing [[3]], the recent uptick suggests that existing control measures may be facing new challenges. Such as, in 2021, the EU/EEA reported 33,527 TB cases, representing a rate of 7.4 per 100,000 population [[3]]. While many countries report fewer than 10 cases per 100,000 people [[1]], the overall burden and the recent increase are cause for concern.

Disproportionate Impact on Children and adolescents

Of particular concern is the increasing prevalence of TB among younger populations. In 2023, a total of 1,689 infections were recorded in children and teenagers under the age of 15. This represents 4.3% of all TB cases and marks a substantial 25% increase compared to the previous year.

The rise in pediatric TB cases highlights the need for targeted interventions and improved screening programs to protect vulnerable populations. Children are more likely to develop severe forms of TB, making early detection and treatment crucial.

Challenges and Future Directions

The resurgence of tuberculosis in Europe underscores the ongoing challenges in eradicating this infectious disease. Factors such as migration, drug resistance, and socioeconomic disparities can contribute to the spread of TB. Continued investment in public health infrastructure, research, and international collaboration is essential to reverse this trend and achieve the goal of eliminating TB as a public health threat.

Moving forward, a multi-faceted approach is needed, including:

• Strengthening TB surveillance and monitoring systems.
• Improving access to diagnosis and treatment, notably for vulnerable populations.
• Addressing the social determinants of TB,such as poverty and inadequate housing.
• Investing in research to develop new and more effective TB vaccines and treatments.